Renaissance Technologies’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Sell |
37,000
-80,300
| -68% | -$756K | ﹤0.01% | 2990 |
|
|
2025
Q1 | $636K | Sell |
117,300
-20,200
| -15% | -$109K | ﹤0.01% | 2639 |
|
|
2024
Q4 | $1.02M | Sell |
137,500
-49,937
| -27% | -$372K | ﹤0.01% | 2490 |
|
|
2024
Q3 | $1.5M | Buy |
187,437
+34,637
| +23% | +$277K | ﹤0.01% | 2204 |
|
|
2024
Q2 | $1.33M | Buy |
152,800
+80,900
| +113% | +$704K | ﹤0.01% | 2153 |
|
|
2024
Q1 | $1.49M | Buy |
+71,900
| New | +$1.49M | ﹤0.01% | 2230 |
|
|
2023
Q3 | – | Sell |
-15,400
| Closed | -$134K | – | 3791 |
|
|
2023
Q2 | $134K | Sell |
15,400
-55,900
| -78% | -$486K | ﹤0.01% | 3401 |
|
|
2023
Q1 | $210K | Buy |
71,300
+47,300
| +197% | +$139K | ﹤0.01% | 3257 |
|
|
2022
Q4 | $84K | Buy |
+24,000
| New | +$84K | ﹤0.01% | 3673 |
|
|
2021
Q2 | – | Sell |
-75,050
| Closed | -$763K | – | 3550 |
|
|
2021
Q1 | $763K | Buy |
75,050
+57,290
| +323% | +$582K | ﹤0.01% | 2732 |
|
|
2020
Q4 | $117K | Buy |
+17,760
| New | +$117K | ﹤0.01% | 3243 |
|
|
2019
Q4 | – | Sell |
-3,589
| Closed | -$65K | – | 3564 |
|
|
2019
Q3 | $65K | Sell |
3,589
-4,557
| -56% | -$82.5K | ﹤0.01% | 3310 |
|
|
2019
Q2 | $134K | Sell |
8,146
-29,732
| -78% | -$489K | ﹤0.01% | 3363 |
|
|
2019
Q1 | $678K | Sell |
37,878
-29,285
| -44% | -$524K | ﹤0.01% | 2826 |
|
|
2018
Q4 | $1.27M | Sell |
67,163
-37,137
| -36% | -$702K | ﹤0.01% | 2464 |
|
|
2018
Q3 | $3.72M | Sell |
104,300
-8,130
| -7% | -$290K | ﹤0.01% | 1978 |
|
|
2018
Q2 | $2.34M | Sell |
112,430
-29,880
| -21% | -$622K | ﹤0.01% | 2188 |
|
|
2018
Q1 | $1.74M | Sell |
142,310
-10,090
| -7% | -$123K | ﹤0.01% | 2399 |
|
|
2017
Q4 | $1.65M | Buy |
152,400
+5,990
| +4% | +$64.7K | ﹤0.01% | 2451 |
|
|
2017
Q3 | $1.76M | Buy |
146,410
+9,610
| +7% | +$115K | ﹤0.01% | 2345 |
|
|
2017
Q2 | $2.34M | Buy |
136,800
+40,496
| +42% | +$692K | ﹤0.01% | 2170 |
|
|
2017
Q1 | $1.66M | Buy |
96,304
+5,604
| +6% | +$96.4K | ﹤0.01% | 2337 |
|
|
2016
Q4 | $1.55M | Buy |
90,700
+22,990
| +34% | +$393K | ﹤0.01% | 2345 |
|
|
2016
Q3 | $2.04M | Buy |
67,710
+9,020
| +15% | +$271K | ﹤0.01% | 2181 |
|
|
2016
Q2 | $1.66M | Buy |
58,690
+1,210
| +2% | +$34.2K | ﹤0.01% | 2307 |
|
|
2016
Q1 | $1.54M | Sell |
57,480
-2,100
| -4% | -$56.3K | ﹤0.01% | 2372 |
|
|
2015
Q4 | $2.87M | Buy |
59,580
+16,098
| +37% | +$776K | 0.01% | 1875 |
|
|
2015
Q3 | $1.59M | Buy |
43,482
+11,859
| +38% | +$433K | ﹤0.01% | 2128 |
|
|
2015
Q2 | $1.19M | Buy |
31,623
+12,143
| +62% | +$458K | ﹤0.01% | 2357 |
|
|
2015
Q1 | $769K | Buy |
19,480
+12,640
| +185% | +$499K | ﹤0.01% | 2433 |
|
|
2014
Q4 | $281K | Sell |
6,840
-5,670
| -45% | -$233K | ﹤0.01% | 2601 |
|
|
2014
Q3 | $553K | Buy |
+12,510
| New | +$553K | ﹤0.01% | 2277 |
|
|
2014
Q1 | – | Sell |
-5,700
| Closed | -$226K | – | 2892 |
|
|
2013
Q4 | $226K | Sell |
5,700
-18,480
| -76% | -$733K | ﹤0.01% | 2583 |
|
|
2013
Q3 | $994K | Buy |
24,180
+19,680
| +437% | +$809K | ﹤0.01% | 2014 |
|
|
2013
Q2 | $174K | Buy |
+4,500
| New | +$174K | ﹤0.01% | 2544 |
|